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Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) imaging detects myocardial scar/fibrosis in hypertrophic 
cardiomyopathy (HCM) patients. LGE has been associated with nonsustained ventricular tachycardia (NSVT), and clinical risk factors for sudden 
cardiac death. We investigated the interaction between left ventricular (LV) maximal wall thickness (mWT) and scar/fibrosis detected by LGE CMR in 
HCM and their association with adverse events such as, NSVT, septal myectomy or diastolic heart failure, (DHF) defined as volume overload requiring 
diuretic therapy.
Methods:  We studied 82 HCM patients with LGE CMR using a 2D PSIR TurboFLASH protocol 15 minutes after administration of 0.2 mmol of 
gadopentetate dimeglumine per kg of body weight acquiring 10-mm short-axis slices from the base to the apex. The percentage of LGE and mWT 
were assessed using automated software (Qmass MR v.61.6, Netherlands). Patients were grouped according to % LGE and mWT. The development of 
NSVT, DHF and myectomy were compared among subgroups.
Results:  LGE was detected in 61 patients (75%) and adverse events developed in 40 (48%). The mWT was significantly higher in patients with LGE 
(2.02±0.67 cm vs 1.62±0.175 cm, p =0.002) than those without. Adverse events increased incrementally with scar extent (Fig. 1) and with mWT and 
scar together (Fig. 2).
Conclusion:  Clinical events in HCM are related both to severity of hypertrophy and extent of LGE. Patients with mWT<2.0 cm without LGE have 
extremely low event rates.
